首页> Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer> P3.01-100 Risk of Gastrointestinal and Hepatic Toxicities in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Osimertinib

P3.01-100 Risk of Gastrointestinal and Hepatic Toxicities in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Osimertinib

导出原文传递

翻译打印收藏纠错

作者： K. Thein ^[1] ; S. Swarup ^[2] ; S. Ball ; M. Quirch ; Y. Vorakunthada ; S. Khan ; F. Hardwicke ; S. Awasthi ; L. Tijani

作者单位： Internal Medicine, Texas Tech University Health Sciences Center, Lubbock ^[1] Hematology Oncology, Texas Tech University Health Sciences Center, Lubbock ^[2]

发布时间 2020-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of thoracic oncology

2018年13卷10期

S904-S904页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Journal of thoracic oncology

2018年13卷10期

S904-S904页

检索历史清除

P3.01-100 Risk of Gastrointestinal and Hepatic Toxicities in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Osimertinib

Journal of thoracic oncology

相似文献

Journal of thoracic oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

P3.01-100 Risk of Gastrointestinal and Hepatic Toxicities in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Osimertinib

Journal of thoracic oncology

相似文献

Journal of thoracic oncology

相关期刊

检索历史清除